Prophylaxis and treatment Effects of Rikkunshito(TJ-43) on delayed gastric emptying (DGE) and gastrointestinal symptoms after pancreatoduodenectomy.
Not Applicable
- Conditions
- Disease which needs to undergo pancreatoduodenectomy (carcinoma of the head of the pancreas, bile duct carcinoma, Papilla Vater carcinoma, duodenal carcinoma, etc.)
- Registration Number
- JPRN-UMIN000012052
- Lead Sponsor
- Sapporo Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patient with active double cancer 2) Patient who has been undergoing chemotherapy 3) Patient who receives KAMPO medicine two weeks before treatment of rikkunshito 4) Patients with serious complications (liver, kidney, heart, blood, or metabolic disorders) 5) Patient with serious hypersensitivity 6) Pregnancy or lactation woman. Patients who hope pregnancy during study 7) Patients considered inappropriate by the study investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Occurrence rate of DGE in patients underwent with pancreatoduodenectomy
- Secondary Outcome Measures
Name Time Method 1) Total dietary intake(TDI) after pancreatoduodenectomy 2) Gastrointestinal symptoms after pancreatoduodenectomy 3) The measurement of circulating gastrointestinal hormone(insulin, c-peptide, gastrin, glucagon and ghrelin)